Invited Speaker

Application of Nanomedicine: As an Emerging Platform for Cancer Therapy
Sanjeeb K. Sahoo
India

The convergence of recent advances in nanotechnology with modern biology and medicine has created the new research domain of nanobiotechnology. The use of nanobiotechnology in medicine is termed nanomedicine. Nanomedicine develops materials and devices operating at the nanoscale to diagnose, treat and monitor diseases. It is expected that nanomedicine would yield implantable devices, 100,000 times smaller than the head of a pin, which will effectively detect diseases without surgical invasion and then eradicate the diseased cells by precisely “pumping” medicine to them. The nanomedicine field joins engineering science with pharmaceutical and medical sciences to translate advances in nanotechnology research into clinical practice. Several nanomaterial-based therapies have already been approved for clinical use and many more nanomaterials are evaluated in clinics. Nanomedicine research includes the development of diagnostics for rapid monitoring, targeted cancer therapies, localized drug delivery, improved cell material interactions, scaffolds for tissue engineering, and gene delivery systems. Successful research and development in nanomedicine where ultimately patients can benefit from these new technologies require the interaction of a multitude of disciplines including material science and engineering, cellular biology and clinical translational research.